Evidence map›Paper›PMID 40229304›Full record

ArticleNature communications2025

Genomic epidemiology and phylodynamics of Acinetobacter baumannii bloodstream isolates in China.

Qixia Luo, Mengru Chang, Ping Lu, Qian Guo, Xiaoqing Jiang, Tingting Xiao, Haoyu Zhang, Yingying Ma, Yan Zhang, Wei Yu and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Integrated clinical and genomic characterization ofJournal of medical microbiology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Caerin 1.1/1.9 peptides controlFrontiers in microbiology · 2026
    Article
  13. Carbapenem-resistantFrontiers in medicine · 2026
    Article
  14. Article
  15. Microbiological eradication of XDRFrontiers in medicine · 2026
    Article
  16. Article
  17. Article
  18. Transfer and Fitness of ISMicroorganisms · 2025
    Article
  19. Threat and Control ofFoods (Basel, Switzerland) · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Qixia Luo *State Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0002-9643-7914
Mengru Chang *Department of Biomedical Engineering, College of Future Technology, Center for Quantitative Biology, and Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.ORCID http://orcid.org/0009-0000-0853-7732
Ping Lu *State Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0009-0008-4797-6621
Qian Guo *Department of Biomedical Engineering, College of Future Technology, Center for Quantitative Biology, and Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Xiaoqing JiangDepartment of Biomedical Engineering, College of Future Technology, Center for Quantitative Biology, and Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.ORCID http://orcid.org/0000-0001-7475-1630
Tingting XiaoState Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.
Haoyu ZhangDepartment of Biomedical Engineering, College of Future Technology, Center for Quantitative Biology, and Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.ORCID http://orcid.org/0000-0003-1383-9406
Yingying MaState Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0003-1267-0581
Yan ZhangDepartment of Biomedical Engineering, College of Future Technology, Center for Quantitative Biology, and Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.ORCID http://orcid.org/0009-0000-2377-9502
Wei YuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0002-1174-596X
Erjia ZhangState Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0009-0001-7996-0906
Yunbo ChenState Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0002-5843-1386
Ping ShenState Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0003-4677-6747
Jinru JiState Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0003-1579-2250
Chaoqun YingState Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0001-8599-3838
Zhiying LiuState Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0002-2060-1597
BRICS Working Group
Huaiqiu ZhuDepartment of Biomedical Engineering, College of Future Technology, Center for Quantitative Biology, and Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China. hqzhu@pku.edu.cn.ORCID http://orcid.org/0000-0002-6376-218X
Yonghong XiaoState Key Laboratory for Diagnosis and Treatment of Infectious Diseases; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical School, College of medicine, Zhejiang University, Hangzhou, China. xiaoyonghong@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent decades, Acinetobacter baumannii has become a major global nosocomial pathogen, with bloodstream infections (BSIs) exhibiting mortality rates exceeding 60% and imposing substantial economic burdens. However, limited large-scale genomic epidemiology has hindered understanding of its population dynamics. Here, we analyzed 1506 non-repetitive BSI-causing A. baumannii isolates from 76 Chinese hospitals over a decade (2011-2021). We identified 149 sequence types (STs) and 101 K-locus types (KLs), revealing increased population diversity. International clone (IC) 2 accounted for 81.74% of isolates, with a notable shift in prevalent STs: ST208 increased while ST191 and ST195 declined, aligning with global trends. ST208 exhibited higher virulence, greater antibiotic resistance, enhanced desiccation tolerance, and more complex transmission patterns compared to ST191 and ST195. Its genomic plasticity drives its adaptation and spread. Using the high-resolution Oxford MLST scheme, this study uncovered greater diversity and genetic factors behind ST208's rise. A. baumannii is evolving from a low-virulence, multidrug-resistant pathogen to a more virulent one, highlighting the urgent need to address its growing threat. These findings have critical implications for infection control and public health policies.

Indexed as

Acinetobacter baumanniiAcinetobacter InfectionsBacteremiaAnti-Bacterial AgentsChinaCross InfectionDrug Resistance, Multiple, BacterialGenetic VariationGenome, BacterialGenomicsHumansMolecular EpidemiologyMultilocus Sequence TypingPhylogenyVirulenceAnti-Bacterial Agents

Identifiers

PMID40229304
PMCPMC11997098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.